UCLA Study to Test an Experimental PET Imaging Agent for Cancer The Ahmanson Biologic Imaging Center at UCLA is looking for patients who have been diagnosed with cancer and/or healthy volunteers who would like to participate in a research project testing a new imaging agent for PET/CT. The purpose of this research study is to determine whether the new PET imaging agent can be used to image cancer. This new PET imaging agent is radioactive, which is decayed by half in less than two hours. Research subjects receive no health benefits from taking part in this study. Research participants will receive financial compensation for their participation ($100). Parking expenditures will be reimbursed. Participants of this research study will undergo one PET/CT scan. Your participation in this study might require up to 4 hours. This includes approximately 120 minutes of imaging in a PET/CT scanner. The new imaging agent will be injected intravenously, which may cause discomfort. For detailed information, please contact: Martin Allen-Auerbach, MD, Tel: (310)-983-1444 or Christiaan Schiepers MD, Tel.: (310) 983-1439.